Return to search

Private Equity Week Wire for Thursday 1/10

SALT LAKE CITY–Wasatch Venture Fund (Wasatch), an affiliate office of Silicon Valley’s Draper Fisher Jurvetson, today announced that Matt Mosman has joined Wasatch as a managing director. Mosman will work out of Wasatch’s Bay Area office, located in San Mateo County and will focus on developing strategic partnerships and follow-on financing for Wasatch’s portfolio companies as well as sourcing investments from the Northern California region.

Mosman brings more than 15 years of operating, advisory and venture management experience to Wasatch, a leading early-stage venture firm, known for pioneering early-stage information technology investments in the Intermountain Region. Mosman joins Wasatch after most recently serving as software giant Oracle, Inc.’s senior vice president of Corporate Development, where he was responsible for corporate development, mergers and acquisitions, joint ventures, spin-offs and technology licensing and establishing and leading their $500 million venture fund. Mosman also served on Oracle’s Product Development Management Committee.

NATICK, MASS. — Vision-Sciences, Inc., (Nasdaq: VSCI) today announced the election of William F. Doyle to the Board of Directors of the Company. Mr. Doyle is a Managing Director at Insight Venture Partners and brings over 20 years experience in the advanced technology and healthcare industries. He focuses on all aspects of software investing and leads Insight’s efforts in the healthcare and pharmaceutical verticals.

Prior to joining Insight, Bill was a member of the Consumer Pharmaceutical and Professional Group Operating Committee and VP, Licensing and Acquisitions of Johnson & Johnson. At J&J, Bill was also Chairman of the Professional Research and Development Council and a director of Johnson & Johnson Development Corporation, J&J’s venture capital subsidiary.

EVERSON, WASH.— Skytalk Communications/SMO Multimedia Corp. (PINK SHEETS:SKLK) announces that it has entered into an engagement letter with Pickens Venture Partners (“PVP”) to provide strategic financial advice.

In addition, PVP has taken an equity position in the Company. PVP is the private-equity affiliate of The Pickens Group LP, a premier Dallas-based investment Firm (“Pickens Group”). Mike Pickens, son of T. Boone Pickens, will be leading the group and working directly with SMO Multimedia to present the Company to larger financial institutions. Pickens Group acts as advisor to Pickens Fund Management (“PFM”) and Pickens Venture Partners. PFM is the asset management arm of the firm and oversees the M3 series of technology hedge funds and the M3 Dow Shire fund-of-funds. PVP provides growth capital to formative companies in the areas of software, data-storage, networking, and the health sciences. Pickens manages over $600,000,000 in assets and its family of funds has consistently posted some of the highest returns to investors in the alternative asset management industry. Pickens funds are eligible to accredited U.S. and non-U.S. institutional and high net worth individuals only and have just recently re-opened to new investors.

SOUTH SAN FRANCISCO, CALIF. — Renovis, Inc., a privately held neurobiopharmaceutical company, announced today the completion of a $34.3 million second round of venture financing. Leading the round is HBM BioVentures AG, a biotechnology investment firm launched by former Roche Holding AG finance chief Henri B Meier. New investors in this round include Applied Genomic Technology Capital (AGTC) Funds; Bioveda Capital; De Novo Ventures; International BM Biomedicine Holdings, Ltd., as advised by Global Biomedical Partners; Vertex Management & Double Helix; and Yasuda Enterprise Development Co., Ltd. Previous investors Venrock Associates, Alta Partners, and Skyline Ventures also participated.
Effective immediately, Nancy M. Crowell, a Founding Partner of AGTC Funds and a member of its Investment Committee, will join Renovis’ Board of Directors, representing Series C investors. Previously, she was a Partner and Managing Director at Cowen and Company, now SG Cowen Securities Corporation. Ms. Crowell founded and managed Cowen’s health care investment banking practice for ten years, building the group to one of the premier national underwriters. She received an MBA from the Haas School of Business at the University of California, Berkeley.

LONDON — Inflexion plc, the mid-market private equity investment company, announces that Geoff Westmore has been appointed to its Advisory Panel.

Mr Westmore was previously a partner at PricewaterhouseCoopers, with his most recent role being that of Global Leader of Transactions Services and Strategic M&A. During this time, he was involved in over 100 completed transactions with a total value of almost